SCHEMBL5046359

SCHEMBL5046359

COC(=O)CCc1cccc(CN(Cc2ccc(-c3nccs3)cc2)S(=O)(=O)c2ccccn2)c1

nearest known ligand 0.60

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
PTGER2 P43116 16/20 0.50
FFAR1 O14842 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5049502 0.90 PTGER2 (0.52) PTGER2FFAR1
SCHEMBL5046825 0.90 PTGER2 (0.60) PTGER2
SCHEMBL5042997 0.89 TAS2R14 (0.49) PTGER2FFAR1
SCHEMBL6059016 0.89 PTGER2 (0.53) PTGER2
SCHEMBL5043195 0.86 TLR7 (0.47) PTGER2FFAR1
SCHEMBL5050304 0.86 PTGER2 (0.52) PTGER2
SCHEMBL5046415 0.85 PTGER2 (0.44) PTGER2
SCHEMBL5043153 0.85 PTGER2 (0.53) PTGER2
SCHEMBL5046399 0.85 CXCR3 (0.49)
SCHEMBL5048116 0.84 PTGER2 (0.60) PTGER2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7442702-B2 Treatment of bone disorders; carboxy derivatives PFIZER INC. (US) 2008-10-28 US disclosed
EP-1021410-B1 PROSTAGLANDIN AGONISTS AND THEIR USE TO TREAT BONE DISORDERS PFIZER (US) 2006-12-27 EP disclosed
US-6498172-B1 (3-(((4-TERT-BUTYL-BENZYL)-(PYRIDINE-3-SULFONYL)-AMINO)-METHYL) -PHENOXY)-ACETIC ACID OR SALT; TREATING SUCH AS OSTEOPOROSIS PFIZER INC. 2002-12-24 US disclosed
EP-1021410-A1 PROSTAGLANDIN AGONISTS AND THEIR USE TO TREAT BONE DISORDERS PFIZER INC. (US) 2000-07-26 EP disclosed
WO-1999019300-A1 PROSTAGLANDIN AGONISTS AND THEIR USE TO TREAT BONE DISORDERS PFIZER INC. (US) 1999-04-22 WO disclosed